全球胰島素筆市場（2023-2030）：規模、佔有率、成長分析與預測（按類型（第一代筆、第二代筆）、用途（預充式筆、可重複使用筆）

胰島素筆市場規模預計將從2021年的10.9億美元成長到2022年的11.6億美元，預測期內年複合成長率為6.26%，到2030年將達到18.8億美元。

近年來，由於糖尿病盛行率的增加以及胰島素筆作為一種方便且方便用戶使用的胰島素輸送方法的日益普及，全球胰島素筆市場呈現顯著成長。胰島素筆具有使用方便、給藥準確、攜帶等優點，成為糖尿病患者的首選。這個市場的推動因素是全球糖尿病人口不斷增加，以及人們對胰島素筆在糖尿病管理中的益處的認知不斷增強，尤其是在新興國家。此外，技術的進步促進了創新胰島素筆的開發，其具有記憶功能、藍牙連接以及與資料追蹤和分析數位平台的兼容性等功能。這些進步透過增加患者便利性和改善治療結果來推動進一步成長。另一方面，儘管全球胰島素筆市場呈現積極成長軌跡，但仍面臨一些挑戰。

有些人恐懼症針頭或抗拒感自行注射，這可能會限制他們對胰島素筆的接受和使用。對針頭的焦慮和恐懼會導致依從性下降和對替代胰島素給藥方法的偏好降低。此外，胰島素筆製造商必須遵守嚴格的法規要求和安全標準，以確保其設備的品質、安全性和有效性。遵守法規和品管措施會增加製造流程的複雜性和成本。

本報告調查了全球胰島素筆市場，並提供了市場概況、市場各種影響因素分析、技術和創新趨勢、法律制度、市場規模趨勢和預測，以及各個細分市場和地區的細分。競爭形勢、主要企業概況等

目錄

• 執行摘要
• 調查方法
• 母市場分析
  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
• 關鍵市場洞察
  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • 啟動分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 重點投資分析
  • 關鍵成功因素
  • 競爭程度
  • 市場動態及展望
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 任務
  • 法規狀況
  • 波特的分析
  • Skyquest 對未來顛覆的獨家見解
• 全球胰島素筆市場：按類型
  • 市場概況
  • 第一代筆
  • 第二代筆
• 全球胰島素筆市場：依用途
  • 市場概況
  • 預填筆
  • 可重複使用的筆
• 全球胰島素筆市場：按地區
  • 市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
• 競爭形勢
  • 前5名企業對比
  • 主要企業市場地位
  • 主要企業的招募策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率
• 主要企業簡介
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi
  • Ypsomed Holding AG
  • BD (Becton, Dickinson and Company)
  • Owen Mumford Ltd
  • Haselmeier AG
  • Medtronic plc
  • Companion Medical, Inc.
  • Biocon Ltd
  • Emperra GmbH E-Health Technologies
  • Bigfoot Biomedical, Inc.
  • Diamesco Co., Ltd.
  • MANNKind Corporation
  • Jiangsu Delfu Medical Device Co., Ltd.
  • Pendiq GmbH
  • Sensile Medical AG
  • Injex Pharma AG
  • Copernicus Sp. z oo
  • Wockhardt Ltd

Insulin Pens Market size was valued at USD 1.09 Billion in 2021 and is poised to grow from USD 1.16 Billion in 2022 to USD 1.88 Billion by 2030, at a CAGR of 6.26% during the forecast period (2023-2030).

The global insulin pens market has witnessed significant growth in recent years due to the increasing prevalence of diabetes and the growing adoption of insulin pens as a convenient and user-friendly method of insulin delivery. Insulin pens offer advantages such as ease of use, accurate dosing, and portability, making them a preferred choice for diabetic patients. The market is driven by the rising diabetic population worldwide, especially in developing countries, coupled with the growing awareness about the benefits of insulin pens in managing diabetes. Furthermore, technological advancements have led to the development of innovative insulin pens with features like memory function, Bluetooth connectivity, and compatibility with digital platforms for data tracking and analysis. These advancements have enhanced patient convenience and improved treatment outcomes, thereby driving market growth. Despite the positive growth trajectory, the global insulin pens market faces certain challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Insulin Pens Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pens Market Segmental Analysis

The global insulin pens market is segmented on the basis of type, usability, and region. By type, the market is segmented into first generation pens and second-generation pens. By usability, the market is segmented into prefilled pens and reusable pens. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Insulin Pens Market Dynamics

Insulin Pens Market Drivers

Technological Advancements

• Continuous technological advancements in insulin pen devices, such as Bluetooth connectivity, memory functions, and smart insulin pens, enhance patient experience and improve treatment outcomes. These advancements drive market growth by offering additional features and functionalities to users.

Preference for Self-Administration

• Insulin pens allow patients to self-administer insulin, reducing the need for healthcare provider assistance and promoting patient independence in managing their diabetes. The preference for self-administration contributes to the increasing adoption of insulin pens.

Insulin Pens Market Restraints

Needle Phobia and Resistance

• Some individuals may have needle phobia or resistance to self-injection, which can limit the acceptance and use of insulin pens. Needle anxiety or fear of injections may result in reduced compliance and preference for alternative insulin delivery methods.

Regulatory and Safety Considerations

• Insulin pen manufacturers need to comply with strict regulatory requirements and safety standards to ensure the quality, safety, and effectiveness of their devices. Compliance with regulations and quality control measures can add complexity and cost to the manufacturing process.

Market Trends of the Global Insulin Pens Key

• Customization and Personalization: There is a growing demand for insulin pens that cater to individual patient needs and preferences. Manufacturers are offering customizable options such as different color choices, dose settings, and even personalized branding. Customizable insulin pens enhance user engagement and satisfaction.
• Focus on Safety Features: Safety is a crucial aspect of insulin pens, and manufacturers are incorporating various safety features to ensure accurate dosing and minimize the risk of medication errors. Needle safety systems, dose confirmation mechanisms, and audible/visual alerts are among the safety features being introduced in insulin pen devices.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Insulin Pens Market by Type
  • Market Overview
  • first generation pens and second-generation pens
• Global Insulin Pens Market by Usability
  • Market Overview
  • prefilled pens and reusable pens
• Global Insulin Pens Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Novo Nordisk A/S - Denmark
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Eli Lilly and Company - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sanofi - France
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ypsomed Holding AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • BD (Becton, Dickinson and Company) - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Owen Mumford Ltd - UK
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Haselmeier AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medtronic plc - Ireland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Companion Medical, Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Biocon Ltd - India
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Emperra GmbH E-Health Technologies - Germany
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Bigfoot Biomedical, Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Diamesco Co., Ltd. - South Korea
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • MANNKind Corporation - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Jiangsu Delfu Medical Device Co., Ltd. - China
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pendiq GmbH - Germany
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sensile Medical AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Injex Pharma AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Copernicus Sp. z o.o. - Poland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Wockhardt Ltd - India
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments